Patents by Inventor Ben Newton

Ben Newton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cinnamic acid amides
    Patent number: 7402683
    Abstract: The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis in illnesses in people or animals, especially diseases of bacterial infection.
    Type: Grant
    Filed: April 14, 2003
    Date of Patent: July 22, 2008
    Assignee: Bayer HealthCare AG
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Ben Newton, Michael Otteneder, Josef Pernerstorfer, Jens Pohlmann, Guido Schiffer, Mitsuyuki Shimada, Niels Svenstrup, Rainer Endermann, Peter Nell
  • Arylamides
    Patent number: 7348357
    Abstract: The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis of diseases in people or animals, especially diseases of bacterial infection.
    Type: Grant
    Filed: July 28, 2003
    Date of Patent: March 25, 2008
    Assignee: Bayer HealthCare AG
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Peter Nell, Ben Newton, Michael Otteneder, Josef Pernerstorfer, Jens Pohlmann, Guido Schiffer, Mitsuyuki Shimada, Niels Svenstrup, Rainer Endermann
  • Novel imaging agents
    Publication number: 20060275215
    Abstract: The present invention relates to diagnostic imaging agents for in vivo imaging. The imaging agents comprise a synthetic caspase-3 inhibitor labelled with an imaging moiety suitable for diagnostic imaging in vivo. The invention also provides pharmaceutical and radiopharmaceutical compositions comprising the imaging agents, together with kits for the preparation of the radiopharmaceuticals. Also described are chelator conjugates of the caspase-3 inhibitor, which are suitable for the preparation of imaging agents comprising a radioactive or paramagnetic metal ion. The imaging agents are useful for the diagnostic imaging and or therapy monitoring in vivo of various disease states where caspase-3 is involved.
    Type: Application
    Filed: November 26, 2004
    Publication date: December 7, 2006
    Inventors: Duncan Hiscock, Ben Newton, Benedicte Guilbert
  • Cinnamic acid amides
    Publication number: 20060178369
    Abstract: The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis in illnesses in people or animals, especially diseases of bacterial infection.
    Type: Application
    Filed: April 14, 2003
    Publication date: August 10, 2006
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Ben Newton, Michael Otteneder, Josef Pernerstorfer, Jens Pohlmann, Guido Schiffer, Mitsuyuki Shimada, Niels Svenstrup, Rainer Endermann
  • Arylamides
    Publication number: 20060173040
    Abstract: The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis of diseases in people or animals, especially diseases of bacterial infection.
    Type: Application
    Filed: July 28, 2003
    Publication date: August 3, 2006
    Applicant: Bayer HealthCare AG
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Peter Nell, Ben Newton, Michael Otteneder, Josef Pernerstorfer, Jens Pohlmann, Guido Schiffer, Mitsuyuki Shimada, Niels Svenstrup, Rainer Endermann
  • Derivatives of andrimide and moiramide b having antibacterial properties
    Publication number: 20050080129
    Abstract: The invention relates to compounds of general formula (I), to a method for the production thereof, to pharmaceutical compositions containing them, and to their use in the treatment and/or prophlaxis of diseases in humans or animals, diseases. The compounds are derivatives of the natural substances andrimide and moiramide B.
    Type: Application
    Filed: November 7, 2002
    Publication date: April 14, 2005
    Applicant: Bayer HealthCare AG
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Ben Newton, Michael Otteneder, Josef Pernerstorfer, Jens Pohlmann, Guido Shiffer, Mitsuyuki Shimada
  • Treatment of bacterial diseases of the respiratory organs
    Publication number: 20040254194
    Abstract: The invention relates to inhalable quinolonecarboxylic acid derivative compositions for local control of diseases of the respiratory organs, in particular of lung diseases.
    Type: Application
    Filed: February 10, 2004
    Publication date: December 16, 2004
    Applicant: Bayer HealthCare AG
    Inventors: Rainer Endermann, Harald Labischinski, Christoph Ladel, Uwe Petersen, Ben Newton